Peckham AM, Ananickal MJ, & Sclar DA. (2018). Gabapentin use, abuse, and the US opioid epidemic: The case for reclassification as a controlled substance and the need for pharmacovigilance. Dove Medical Press.
Chicago Style (17th ed.) CitationPeckham AM, Ananickal MJ, and Sclar DA. Gabapentin Use, Abuse, and the US Opioid Epidemic: The Case for Reclassification as a Controlled Substance and the Need for Pharmacovigilance. Dove Medical Press, 2018.
MLA (9th ed.) CitationPeckham AM, et al. Gabapentin Use, Abuse, and the US Opioid Epidemic: The Case for Reclassification as a Controlled Substance and the Need for Pharmacovigilance. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.